Search

Learning more about epithelioid hemangioendothelioma (EHE) is an ongoing mission of MSK’s sarcoma research.

… Wednesday, July 21, 2021 Memorial Sloan Kettering has been a leader in the care of sarcoma patients for decades, treating about 70% of the cases in the New York City tri-state area. A disease largely affecting young people, sarcoma is a rare cancer of the bones and soft tissues with more than 50 subtypes

Memorial Sloan Kettering Cancer Center (MSK) announced today that the U.S. Food and Drug Administration (FDA) has approved the oral MEK inhibitor drug cobimetinib (COTELLIC®) for the treatment of adult patients with the family of blood diseases know as histiocytic neoplasms (HN). These diseases include: Erdheim-Chester Disease, Rosai-Dorfman, and Langerhans Histiocytosis. Cobimetinib is an oral inhibitor of MEK1 and MEK2 currently approved to treat melanoma.

… Tuesday, November 1, 2022 Memorial Sloan Kettering Cancer Center (MSK) announced today that the U.S. Food and Drug Administration (FDA) has approved the oral MEK inhibitor drug cobimetinib (Cotellic ® ) for the treatment of adult patients with the family of blood diseases known as histiocytic neoplasms

Learn how high-intensity focused ultrasound (HIFU) can help some men with prostate cancer avoid surgery or radiation.

… Monday, June 30, 2025 For people with  prostate cancer  considered “intermediate risk” —  small tumors confined to one area of the prostate – doctors are increasingly using a treatment known as  focal therapy  (partial gland ablation). One approach uses an advanced and highly precise energy source known

As we reflect in this season of gratitude, MSK Kids, the pediatric cancer program at Memorial Sloan Kettering, is grateful for our pediatric patients and their families. Patients just like Rihanna.

… Tuesday, November 24, 2020 MSK Kid, Rihanna, and her family visit New York City to see her billboard. MSK Kid, Rihanna, and her family visit New York City to see her billboard. MSK Kid, Rihanna, and her family visit New York City to see her billboard. MSK Kid, Rihanna, and her family visit New York City

In a video interview and a panel discussion held at MSK last week, an eminent scientist, his family, and colleagues reflected on the experience of illness.

… Tuesday, November 22, 2016 Cancer immunologists Alan Houghton and Jedd Wolchok Alan Houghton (left) with colleague and former student Jedd Wolchok in 2004. Colin Houghton and Meryl Houghton Colin Houghton and Meryl Houghton From left to right: Colin, Meryl, and Sean Houghton; Jedd Wolchok; Paul Chapman

The drug targets a protein called HER2 found on some salivary gland tumors.

… Thursday, January 23, 2020 Albert Kuchler discussing his treatment results with MSK oncologist Bob Li at a recent clinic visit. Albert Kuchler discusses his excellent treatment results with MSK oncologist Bob Li at a recent clinic visit. MSK oncologist Bob Li Dr. Li is developing new clinical trials

Sergio Giralt, MD, has been appointed Chief of the Adult Bone Marrow Transplantation Service in the Division of Hematologic Oncology in the Department of Medicine at Memorial Sloan Kettering Cancer Center.

… Tuesday, June 1, 2010 Sergio Giralt, MD , has been appointed Chief of the Adult Bone Marrow Transplantation Service in the Division of Hematologic Oncology in the Department of Medicine at Memorial Sloan Kettering Cancer Center. “We’re very pleased to have Dr. Giralt, a recognized leader in the field

A new study shows how evolution and natural selection influence clonal hematopoiesis, an aging-related blood condition that increases the risk of blood cancer and cardiovascular disease.

… Monday, August 30, 2021 Artificial intelligence (AI) and machine learning allow researchers to study databases that otherwise would be too large and complex. In a recent study, Sloan Kettering Institute computational biologist Quaid Morris and collaborators used models to study an aging-related blood

A collaborative team of researchers from Memorial Sloan Kettering has determined the mechanism for a biological process that plays a key role in regulating cellular behavior.

… Tuesday, June 1, 2010 Summary A collaborative team of researchers from Memorial Sloan Kettering has determined the mechanism for a biological process that plays a key role in regulating cellular behavior. A collaborative team of researchers from Memorial Sloan Kettering has determined the mechanism for

The May 20 installment of “MSK Science Spotlight” will feature guest speaker, Katherine High, MD, Professor Emerita, Perelman School of Medicine of the University of Pennsylvania; Co-founder and former President and Head of R&D, Spark Therapeutics.

… Wednesday, May 20, 2020 MSK Science Spotlight The May 20 installment of “ MSK Science Spotlight ” will feature guest speaker, Katherine High, MD, Professor Emerita, Perelman School of Medicine of the University of Pennsylvania; Co-founder and former President and Head of R&D, Spark Therapeutics. Hosted